nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALB—Erlotinib—pancreatic cancer	0.0776	0.361	CbGbCtD
Fospropofol—ALB—Irinotecan—pancreatic cancer	0.0701	0.326	CbGbCtD
Fospropofol—ALB—Fluorouracil—pancreatic cancer	0.0672	0.313	CbGbCtD
Fospropofol—Hypoxemia—Gemcitabine—pancreatic cancer	0.0482	0.104	CcSEcCtD
Fospropofol—ALPL—NOTCH1 regulation of human endothelial cell calcification—JAG2—pancreatic cancer	0.0371	0.116	CbGpPWpGaD
Fospropofol—ALPL—NOTCH1 regulation of human endothelial cell calcification—JAG1—pancreatic cancer	0.0296	0.0923	CbGpPWpGaD
Fospropofol—ALPL—NOTCH1 regulation of human endothelial cell calcification—NOTCH1—pancreatic cancer	0.0163	0.051	CbGpPWpGaD
Fospropofol—Hypoxia—Gemcitabine—pancreatic cancer	0.0152	0.0328	CcSEcCtD
Fospropofol—Tingling sensation—Fluorouracil—pancreatic cancer	0.0118	0.0255	CcSEcCtD
Fospropofol—Stinging—Fluorouracil—pancreatic cancer	0.0117	0.0253	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—PTCH1—pancreatic cancer	0.0114	0.0357	CbGpPWpGaD
Fospropofol—ALPL—Endochondral Ossification—PTHLH—pancreatic cancer	0.0114	0.0357	CbGpPWpGaD
Fospropofol—Hepatic failure—Tamoxifen—pancreatic cancer	0.0114	0.0245	CcSEcCtD
Fospropofol—Hepatic failure—Erlotinib—pancreatic cancer	0.0113	0.0242	CcSEcCtD
Fospropofol—Hepatic failure—Sunitinib—pancreatic cancer	0.00974	0.021	CcSEcCtD
Fospropofol—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—pancreatic cancer	0.00956	0.0299	CbGpPWpGaD
Fospropofol—Hepatic failure—Gemcitabine—pancreatic cancer	0.00782	0.0168	CcSEcCtD
Fospropofol—Mediastinal disorder—Erlotinib—pancreatic cancer	0.00631	0.0136	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—PLAU—pancreatic cancer	0.00622	0.0194	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—HIF1A—pancreatic cancer	0.00613	0.0191	CbGpPWpGaD
Fospropofol—Stinging—Epirubicin—pancreatic cancer	0.00572	0.0123	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—NFKBIA—pancreatic cancer	0.00558	0.0174	CbGpPWpGaD
Fospropofol—Hepatic failure—Docetaxel—pancreatic cancer	0.00555	0.0119	CcSEcCtD
Fospropofol—Angiopathy—Sunitinib—pancreatic cancer	0.0055	0.0118	CcSEcCtD
Fospropofol—Mediastinal disorder—Sunitinib—pancreatic cancer	0.00546	0.0117	CcSEcCtD
Fospropofol—Cough—Tamoxifen—pancreatic cancer	0.00537	0.0116	CcSEcCtD
Fospropofol—Cough—Erlotinib—pancreatic cancer	0.00532	0.0114	CcSEcCtD
Fospropofol—Stinging—Doxorubicin—pancreatic cancer	0.00529	0.0114	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00515	0.0111	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—CNR1—pancreatic cancer	0.00505	0.0158	CbGpPWpGaD
Fospropofol—ALB—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.00504	0.0157	CbGpPWpGaD
Fospropofol—GABRG3—Ion channel transport—FXYD3—pancreatic cancer	0.00503	0.0157	CbGpPWpGaD
Fospropofol—GABRB1—Ion channel transport—FXYD3—pancreatic cancer	0.00495	0.0155	CbGpPWpGaD
Fospropofol—Nervous system disorder—Erlotinib—pancreatic cancer	0.00488	0.0105	CcSEcCtD
Fospropofol—Skin disorder—Erlotinib—pancreatic cancer	0.00483	0.0104	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—MMP2—pancreatic cancer	0.00479	0.0149	CbGpPWpGaD
Fospropofol—GABRA6—Ion channel transport—FXYD3—pancreatic cancer	0.00469	0.0146	CbGpPWpGaD
Fospropofol—Ventricular tachycardia—Epirubicin—pancreatic cancer	0.00463	0.00997	CcSEcCtD
Fospropofol—GABRA4—Ion channel transport—FXYD3—pancreatic cancer	0.00463	0.0144	CbGpPWpGaD
Fospropofol—Cough—Sunitinib—pancreatic cancer	0.0046	0.0099	CcSEcCtD
Fospropofol—Angiopathy—Irinotecan—pancreatic cancer	0.00453	0.00974	CcSEcCtD
Fospropofol—Paraesthesia—Tamoxifen—pancreatic cancer	0.00451	0.00971	CcSEcCtD
Fospropofol—Mediastinal disorder—Irinotecan—pancreatic cancer	0.0045	0.00967	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00446	0.00959	CcSEcCtD
Fospropofol—Angiopathy—Gemcitabine—pancreatic cancer	0.00441	0.00949	CcSEcCtD
Fospropofol—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00438	0.00942	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00434	0.00933	CcSEcCtD
Fospropofol—Pain—Tamoxifen—pancreatic cancer	0.0043	0.00924	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00429	0.00923	CcSEcCtD
Fospropofol—Ventricular tachycardia—Doxorubicin—pancreatic cancer	0.00429	0.00922	CcSEcCtD
Fospropofol—Pain—Erlotinib—pancreatic cancer	0.00425	0.00914	CcSEcCtD
Fospropofol—GABRB2—Ion channel transport—FXYD3—pancreatic cancer	0.00423	0.0132	CbGpPWpGaD
Fospropofol—Nervous system disorder—Sunitinib—pancreatic cancer	0.00422	0.00908	CcSEcCtD
Fospropofol—Skin disorder—Sunitinib—pancreatic cancer	0.00418	0.00899	CcSEcCtD
Fospropofol—GABRA5—Ion channel transport—FXYD3—pancreatic cancer	0.00411	0.0128	CbGpPWpGaD
Fospropofol—GABRA3—Ion channel transport—FXYD3—pancreatic cancer	0.00404	0.0126	CbGpPWpGaD
Fospropofol—GABRA2—Ion channel transport—FXYD3—pancreatic cancer	0.00397	0.0124	CbGpPWpGaD
Fospropofol—GABRB3—Ion channel transport—FXYD3—pancreatic cancer	0.00394	0.0123	CbGpPWpGaD
Fospropofol—GABRG2—Ion channel transport—FXYD3—pancreatic cancer	0.00387	0.0121	CbGpPWpGaD
Fospropofol—Paraesthesia—Sunitinib—pancreatic cancer	0.00386	0.00831	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—CASP3—pancreatic cancer	0.00381	0.0119	CbGpPWpGaD
Fospropofol—Cough—Irinotecan—pancreatic cancer	0.00379	0.00815	CcSEcCtD
Fospropofol—Hepatic failure—Epirubicin—pancreatic cancer	0.00374	0.00805	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00372	0.00799	CcSEcCtD
Fospropofol—Cough—Gemcitabine—pancreatic cancer	0.00369	0.00794	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—MMP9—pancreatic cancer	0.00369	0.0115	CbGpPWpGaD
Fospropofol—Pain—Sunitinib—pancreatic cancer	0.00368	0.00792	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—MMP9—pancreatic cancer	0.0036	0.0112	CbGpPWpGaD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00358	0.0077	CcSEcCtD
Fospropofol—Pruritus—Tamoxifen—pancreatic cancer	0.00356	0.00765	CcSEcCtD
Fospropofol—Pruritus—Erlotinib—pancreatic cancer	0.00352	0.00757	CcSEcCtD
Fospropofol—Nervous system disorder—Irinotecan—pancreatic cancer	0.00348	0.00748	CcSEcCtD
Fospropofol—Hepatic failure—Doxorubicin—pancreatic cancer	0.00346	0.00745	CcSEcCtD
Fospropofol—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00339	0.00728	CcSEcCtD
Fospropofol—GABRA1—Ion channel transport—FXYD3—pancreatic cancer	0.00338	0.0106	CbGpPWpGaD
Fospropofol—Skin disorder—Gemcitabine—pancreatic cancer	0.00335	0.00722	CcSEcCtD
Fospropofol—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00333	0.00716	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—SRC—pancreatic cancer	0.00332	0.0104	CbGpPWpGaD
Fospropofol—Hypotension—Irinotecan—pancreatic cancer	0.00331	0.00713	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—VEGFA—pancreatic cancer	0.00331	0.0103	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—TSC2—pancreatic cancer	0.00328	0.0102	CbGpPWpGaD
Fospropofol—Hypotension—Gemcitabine—pancreatic cancer	0.00323	0.00694	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—STAT3—pancreatic cancer	0.0032	0.00999	CbGpPWpGaD
Fospropofol—Vomiting—Tamoxifen—pancreatic cancer	0.00319	0.00687	CcSEcCtD
Fospropofol—Paraesthesia—Irinotecan—pancreatic cancer	0.00318	0.00685	CcSEcCtD
Fospropofol—Hypotension—Fluorouracil—pancreatic cancer	0.00317	0.00682	CcSEcCtD
Fospropofol—Vomiting—Erlotinib—pancreatic cancer	0.00316	0.0068	CcSEcCtD
Fospropofol—Headache—Tamoxifen—pancreatic cancer	0.00315	0.00677	CcSEcCtD
Fospropofol—Angiopathy—Docetaxel—pancreatic cancer	0.00313	0.00673	CcSEcCtD
Fospropofol—Headache—Erlotinib—pancreatic cancer	0.00311	0.0067	CcSEcCtD
Fospropofol—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00311	0.00669	CcSEcCtD
Fospropofol—Paraesthesia—Gemcitabine—pancreatic cancer	0.0031	0.00667	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00306	0.00658	CcSEcCtD
Fospropofol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00305	0.00656	CcSEcCtD
Fospropofol—Pruritus—Sunitinib—pancreatic cancer	0.00304	0.00655	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—TGFB1—pancreatic cancer	0.00304	0.00949	CbGpPWpGaD
Fospropofol—Pain—Irinotecan—pancreatic cancer	0.00303	0.00652	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—NFKBIA—pancreatic cancer	0.00299	0.00933	CbGpPWpGaD
Fospropofol—Nausea—Tamoxifen—pancreatic cancer	0.00298	0.00642	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00298	0.00641	CcSEcCtD
Fospropofol—Pain—Gemcitabine—pancreatic cancer	0.00295	0.00635	CcSEcCtD
Fospropofol—Nausea—Erlotinib—pancreatic cancer	0.00295	0.00635	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00293	0.00631	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—EGFR—pancreatic cancer	0.00291	0.00908	CbGpPWpGaD
Fospropofol—Pain—Fluorouracil—pancreatic cancer	0.0029	0.00625	CcSEcCtD
Fospropofol—Vomiting—Sunitinib—pancreatic cancer	0.00274	0.00589	CcSEcCtD
Fospropofol—Headache—Sunitinib—pancreatic cancer	0.0027	0.0058	CcSEcCtD
Fospropofol—ALB—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.00268	0.00838	CbGpPWpGaD
Fospropofol—Cough—Docetaxel—pancreatic cancer	0.00262	0.00564	CcSEcCtD
Fospropofol—Nausea—Sunitinib—pancreatic cancer	0.00256	0.0055	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00254	0.00546	CcSEcCtD
Fospropofol—Pruritus—Gemcitabine—pancreatic cancer	0.00244	0.00526	CcSEcCtD
Fospropofol—Nervous system disorder—Docetaxel—pancreatic cancer	0.0024	0.00517	CcSEcCtD
Fospropofol—Pruritus—Fluorouracil—pancreatic cancer	0.0024	0.00517	CcSEcCtD
Fospropofol—Skin disorder—Docetaxel—pancreatic cancer	0.00238	0.00512	CcSEcCtD
Fospropofol—Hypotension—Docetaxel—pancreatic cancer	0.00229	0.00493	CcSEcCtD
Fospropofol—Vomiting—Irinotecan—pancreatic cancer	0.00225	0.00485	CcSEcCtD
Fospropofol—Headache—Irinotecan—pancreatic cancer	0.00222	0.00478	CcSEcCtD
Fospropofol—Paraesthesia—Docetaxel—pancreatic cancer	0.0022	0.00473	CcSEcCtD
Fospropofol—Vomiting—Gemcitabine—pancreatic cancer	0.0022	0.00472	CcSEcCtD
Fospropofol—Headache—Gemcitabine—pancreatic cancer	0.00216	0.00465	CcSEcCtD
Fospropofol—Vomiting—Fluorouracil—pancreatic cancer	0.00216	0.00464	CcSEcCtD
Fospropofol—Headache—Fluorouracil—pancreatic cancer	0.00213	0.00458	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00212	0.00455	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—AKT1—pancreatic cancer	0.00211	0.0066	CbGpPWpGaD
Fospropofol—Angiopathy—Epirubicin—pancreatic cancer	0.00211	0.00454	CcSEcCtD
Fospropofol—Nausea—Irinotecan—pancreatic cancer	0.00211	0.00453	CcSEcCtD
Fospropofol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.0021	0.00451	CcSEcCtD
Fospropofol—Pain—Docetaxel—pancreatic cancer	0.0021	0.00451	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—AKT1—pancreatic cancer	0.00206	0.00643	CbGpPWpGaD
Fospropofol—Nausea—Gemcitabine—pancreatic cancer	0.00205	0.00441	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—CASP3—pancreatic cancer	0.00204	0.00637	CbGpPWpGaD
Fospropofol—Nausea—Fluorouracil—pancreatic cancer	0.00202	0.00434	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—CTNNB1—pancreatic cancer	0.00197	0.00614	CbGpPWpGaD
Fospropofol—ALB—HDL-mediated lipid transport—APOE—pancreatic cancer	0.00195	0.0061	CbGpPWpGaD
Fospropofol—Angiopathy—Doxorubicin—pancreatic cancer	0.00195	0.0042	CcSEcCtD
Fospropofol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00194	0.00417	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—SRC—pancreatic cancer	0.00178	0.00555	CbGpPWpGaD
Fospropofol—Cough—Epirubicin—pancreatic cancer	0.00177	0.0038	CcSEcCtD
Fospropofol—GABRG3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00175	0.00546	CbGpPWpGaD
Fospropofol—Pruritus—Docetaxel—pancreatic cancer	0.00173	0.00373	CcSEcCtD
Fospropofol—GABRB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00172	0.00538	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—STAT3—pancreatic cancer	0.00171	0.00535	CbGpPWpGaD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00171	0.00368	CcSEcCtD
Fospropofol—ALB—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.00169	0.00528	CbGpPWpGaD
Fospropofol—Cough—Doxorubicin—pancreatic cancer	0.00164	0.00352	CcSEcCtD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00163	0.0051	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00163	0.00509	CbGpPWpGaD
Fospropofol—Nervous system disorder—Epirubicin—pancreatic cancer	0.00162	0.00349	CcSEcCtD
Fospropofol—GABRA4—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00161	0.00503	CbGpPWpGaD
Fospropofol—Skin disorder—Epirubicin—pancreatic cancer	0.00161	0.00345	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00158	0.00341	CcSEcCtD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00157	0.00491	CbGpPWpGaD
Fospropofol—Vomiting—Docetaxel—pancreatic cancer	0.00156	0.00335	CcSEcCtD
Fospropofol—Hypotension—Epirubicin—pancreatic cancer	0.00154	0.00332	CcSEcCtD
Fospropofol—Headache—Docetaxel—pancreatic cancer	0.00154	0.0033	CcSEcCtD
Fospropofol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.0015	0.00323	CcSEcCtD
Fospropofol—Skin disorder—Doxorubicin—pancreatic cancer	0.00149	0.0032	CcSEcCtD
Fospropofol—Paraesthesia—Epirubicin—pancreatic cancer	0.00148	0.00319	CcSEcCtD
Fospropofol—GABRB2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00147	0.0046	CbGpPWpGaD
Fospropofol—Nausea—Docetaxel—pancreatic cancer	0.00146	0.00313	CcSEcCtD
Fospropofol—GABRA5—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00143	0.00447	CbGpPWpGaD
Fospropofol—Hypotension—Doxorubicin—pancreatic cancer	0.00143	0.00307	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00143	0.00307	CcSEcCtD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00143	0.00445	CbGpPWpGaD
Fospropofol—Pain—Epirubicin—pancreatic cancer	0.00141	0.00304	CcSEcCtD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00141	0.00439	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00141	0.00439	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00138	0.00431	CbGpPWpGaD
Fospropofol—Paraesthesia—Doxorubicin—pancreatic cancer	0.00137	0.00295	CcSEcCtD
Fospropofol—GABRB3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00137	0.00428	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00135	0.00421	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00133	0.00415	CbGpPWpGaD
Fospropofol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00132	0.00284	CcSEcCtD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00131	0.0041	CbGpPWpGaD
Fospropofol—Pain—Doxorubicin—pancreatic cancer	0.00131	0.00281	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—HRAS—pancreatic cancer	0.00125	0.0039	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00124	0.00386	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.0012	0.00375	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00118	0.00368	CbGpPWpGaD
Fospropofol—Pruritus—Epirubicin—pancreatic cancer	0.00117	0.00252	CcSEcCtD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00117	0.00364	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00115	0.00358	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00113	0.00351	CbGpPWpGaD
Fospropofol—ALB—Lipoprotein metabolism—APOE—pancreatic cancer	0.00112	0.0035	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00112	0.00349	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—AKT1—pancreatic cancer	0.0011	0.00345	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.0011	0.00343	CbGpPWpGaD
Fospropofol—Pruritus—Doxorubicin—pancreatic cancer	0.00108	0.00233	CcSEcCtD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00108	0.00338	CbGpPWpGaD
Fospropofol—Vomiting—Epirubicin—pancreatic cancer	0.00105	0.00226	CcSEcCtD
Fospropofol—Headache—Epirubicin—pancreatic cancer	0.00104	0.00223	CcSEcCtD
Fospropofol—GABRB3—BDNF signaling pathway—CNR1—pancreatic cancer	0.00103	0.0032	CbGpPWpGaD
Fospropofol—Nausea—Epirubicin—pancreatic cancer	0.000982	0.00211	CcSEcCtD
Fospropofol—Vomiting—Doxorubicin—pancreatic cancer	0.000972	0.00209	CcSEcCtD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00096	0.003	CbGpPWpGaD
Fospropofol—Headache—Doxorubicin—pancreatic cancer	0.000958	0.00206	CcSEcCtD
Fospropofol—Nausea—Doxorubicin—pancreatic cancer	0.000908	0.00195	CcSEcCtD
Fospropofol—ALB—Vitamin B12 Metabolism—SOD2—pancreatic cancer	0.000896	0.0028	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000894	0.00279	CbGpPWpGaD
Fospropofol—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—pancreatic cancer	0.000874	0.00273	CbGpPWpGaD
Fospropofol—ALB—Lipid and lipoprotein metabolism—APOE—pancreatic cancer	0.000746	0.00233	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—APOE—pancreatic cancer	0.000734	0.00229	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—SOD2—pancreatic cancer	0.000729	0.00228	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000674	0.0021	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—TSC2—pancreatic cancer	0.000666	0.00208	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000641	0.002	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—NFKBIA—pancreatic cancer	0.000607	0.0019	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.000579	0.00181	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000549	0.00172	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000539	0.00168	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000537	0.00168	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000531	0.00166	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000502	0.00157	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000496	0.00155	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—EGF—pancreatic cancer	0.000457	0.00143	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000454	0.00142	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000441	0.00138	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	0.000435	0.00136	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000433	0.00135	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000425	0.00133	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000422	0.00132	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000415	0.0013	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—CASP3—pancreatic cancer	0.000414	0.00129	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000408	0.00128	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—CTNNB1—pancreatic cancer	0.000399	0.00125	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000363	0.00113	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—SRC—pancreatic cancer	0.000361	0.00113	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000348	0.00109	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—STAT3—pancreatic cancer	0.000348	0.00109	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.00034	0.00106	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000334	0.00104	CbGpPWpGaD
Fospropofol—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000331	0.00103	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNA5—pancreatic cancer	0.000328	0.00102	CbGpPWpGaD
Fospropofol—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000326	0.00102	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000325	0.00102	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000321	0.001	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PPP2R5B—pancreatic cancer	0.00031	0.000968	CbGpPWpGaD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000309	0.000965	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000305	0.000952	CbGpPWpGaD
Fospropofol—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000285	0.000888	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000283	0.000884	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000279	0.000871	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—VEGFA—pancreatic cancer	0.000276	0.000863	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TNF—pancreatic cancer	0.000276	0.000863	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000271	0.000846	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000266	0.000831	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	0.000263	0.000822	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000262	0.000817	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.00026	0.000811	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000255	0.000797	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—HRAS—pancreatic cancer	0.000254	0.000793	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TGFB1—pancreatic cancer	0.000254	0.000792	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000249	0.000778	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000245	0.000766	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TP53—pancreatic cancer	0.000244	0.000761	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000243	0.000757	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	0.000242	0.000755	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000232	0.000725	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000229	0.000716	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—AKT1—pancreatic cancer	0.000224	0.0007	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000223	0.000696	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	0.00022	0.000685	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.00021	0.000655	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000208	0.000648	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	0.000205	0.00064	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000204	0.000636	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	0.000203	0.000633	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.0002	0.000625	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000197	0.000614	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000195	0.00061	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000192	0.000599	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—HRAS—pancreatic cancer	0.000191	0.000596	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—HRAS—pancreatic cancer	0.000188	0.000587	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CD44—pancreatic cancer	0.000186	0.00058	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	0.00018	0.000563	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNA1—pancreatic cancer	0.00018	0.000562	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—HRAS—pancreatic cancer	0.000178	0.000556	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—HRAS—pancreatic cancer	0.000176	0.000549	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PRSS1—pancreatic cancer	0.00017	0.000532	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000168	0.000523	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNA2—pancreatic cancer	0.000167	0.000523	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—HRAS—pancreatic cancer	0.000161	0.000502	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	0.000157	0.000491	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—HRAS—pancreatic cancer	0.000156	0.000487	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—HRAS—pancreatic cancer	0.000153	0.000479	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—HRAS—pancreatic cancer	0.000151	0.00047	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—HRAS—pancreatic cancer	0.00015	0.000467	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ARG2—pancreatic cancer	0.000148	0.000462	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—HRAS—pancreatic cancer	0.000147	0.000459	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TYMP—pancreatic cancer	0.000129	0.000403	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—HRAS—pancreatic cancer	0.000128	0.000401	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	0.000126	0.000393	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	0.000123	0.000383	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAU—pancreatic cancer	0.000119	0.000371	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	0.000113	0.000351	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000107	0.000333	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CG—pancreatic cancer	0.000106	0.00033	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—EGF—pancreatic cancer	0.000104	0.000326	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GLP1R—pancreatic cancer	0.000104	0.000325	CbGpPWpGaD
Fospropofol—ALB—Metabolism—DPYD—pancreatic cancer	0.000102	0.00032	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC2A2—pancreatic cancer	9.72e-05	0.000304	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.62e-05	0.0003	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	9.58e-05	0.000299	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CD—pancreatic cancer	9.29e-05	0.00029	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.29e-05	0.00029	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.46e-05	0.000264	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CB—pancreatic cancer	8.1e-05	0.000253	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	7.82e-05	0.000244	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CD44—pancreatic cancer	7.53e-05	0.000235	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.37e-05	0.00023	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.3e-05	0.000228	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GCG—pancreatic cancer	7.22e-05	0.000225	CbGpPWpGaD
Fospropofol—ALB—Metabolism—STK11—pancreatic cancer	6.79e-05	0.000212	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SRC—pancreatic cancer	6.49e-05	0.000203	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.37e-05	0.000199	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VEGFA—pancreatic cancer	6.32e-05	0.000197	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NRAS—pancreatic cancer	6.24e-05	0.000195	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TYMS—pancreatic cancer	5.84e-05	0.000182	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB1—pancreatic cancer	5.8e-05	0.000181	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—KRAS—pancreatic cancer	5.37e-05	0.000168	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CA—pancreatic cancer	4.94e-05	0.000154	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TP53—pancreatic cancer	4.78e-05	0.000149	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOE—pancreatic cancer	4.75e-05	0.000148	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—HRAS—pancreatic cancer	4.57e-05	0.000143	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.49e-05	0.00014	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CG—pancreatic cancer	4.28e-05	0.000134	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPARG—pancreatic cancer	4.14e-05	0.000129	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—AKT1—pancreatic cancer	4.03e-05	0.000126	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CD—pancreatic cancer	3.77e-05	0.000118	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CB—pancreatic cancer	3.28e-05	0.000103	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTGS2—pancreatic cancer	3.25e-05	0.000102	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTEN—pancreatic cancer	2.84e-05	8.86e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CA—pancreatic cancer	2e-05	6.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AKT1—pancreatic cancer	1.64e-05	5.11e-05	CbGpPWpGaD
